References
Jan 28, 1994·Cell·T A Springer
Jul 1, 1995·Gastroenterology·H M van DullemenJ Woody
Dec 13, 2000·Gastroenterology·R N FedorakB Feagan
Apr 21, 2001·Gastroenterology·S SchreiberUNKNOWN German ICAM-1 Study Group
Aug 7, 2001·Gastroenterology·F H GordonR E Pounder
Jun 22, 2002·Gut·B R YacyshynUNKNOWN ISIS 2302-CS9 Investigators
Jan 3, 2003·The New England Journal of Medicine·Subrata GhoshUNKNOWN Natalizumab Pan-European Study Group
Jun 28, 2003·Trends in Molecular Medicine·Klaus Ley
Mar 15, 2005·Gastroenterology·Yu OyamaRichard K Burt
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
Feb 14, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bruce YacyshynEmil Chuang
May 9, 2007·Gastroenterology·Stephan R TarganUNKNOWN International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group
Aug 19, 2008·Gastroenterology·William J SandbornUNKNOWN Ustekinumab Crohn's Disease Study Group
Feb 10, 2009·Gut·A Di SabatinoS L Pender
Jun 11, 2009·The Journal of Pharmacology and Experimental Therapeutics·Dulce SolerEric R Fedyk
Jun 25, 2009·Arthritis Research & Therapy·Jacques TebibJean Sibilia
Aug 14, 2009·Current Opinion in Pharmacology·Maximilian J Waldner, Markus F Neurath
Nov 20, 2009·The New England Journal of Medicine·Clara Abraham, Judy H Cho
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Sep 15, 2010·Blood·Richard K BurtYu Oyama
Oct 6, 2010·Gut·Marjolijn DuijvesteinDaniel W Hommes
Dec 2, 2010·Alimentary Pharmacology & Therapeutics·U KopylovS Ben-Horin
Dec 21, 2010·Digestive Diseases and Sciences·Dustin G JamesChristian D Stone
Feb 15, 2011·Gut·Séverine VermeireWojciech Niezychowski
May 5, 2011·Alimentary Pharmacology & Therapeutics·S DaneseW Reinisch
Dec 30, 2011·Inflammopharmacology·Saskia Thomas, Daniel C Baumgart
Mar 16, 2012·The New England Journal of Medicine·Giancarlo ComiUNKNOWN ALLEGRO Study Group
May 18, 2012·The New England Journal of Medicine·Gary BloomgrenCarmen Bozic
Jun 22, 2012·Gut·Paul J RutgeertsSharon O'Byrne
Aug 17, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN Study A3921063 Investigators
Oct 12, 2012·International Journal of Colorectal Disease·F de la PortillaA Galindo
Oct 19, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN CERTIFI Study Group
Dec 4, 2012·Journal of Crohn's & Colitis·Martin BortlikMilan Lukas
Feb 22, 2013·British Journal of Pharmacology·W J PanD C Borie
Mar 7, 2013·Gut·Lloyd MayerAllison Y Luo
Mar 8, 2013·Gut·Cornelia TillackStephan Brand
Mar 26, 2013·PloS One·Satish KeshavUNKNOWN Prospective Randomized Oral-Therapy Evaluation in Crohn’s Disease Trial-1 PROTECT-1 Study Group
Apr 6, 2013·Expert Review of Clinical Immunology·Monica Cesarini, Gionata Fiorino
Jun 25, 2013·Autoimmunity Reviews·Shomron Ben-HorinYehuda Chowers
Jul 24, 2013·Gut·Casper SteenholdtMark Andrew Ainsworth
Aug 2, 2013·Immunotherapy·Reena Khanna, Brian G Feagan
Aug 24, 2013·The New England Journal of Medicine·William J SandbornUNKNOWN GEMINI 2 Study Group
Oct 10, 2013·Current Drug Targets·Mariangela AlloccaSilvio Danese
Nov 20, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Monica CesariniGionata Fiorino
Jan 21, 2014·Annales pharmaceutiques françaises·P Bourlioux
Feb 1, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornUNKNOWN Study A3921043 Investigators
Feb 4, 2014·Journal of Crohn's & Colitis·Per MaritsMichael Eberhardson
Mar 13, 2014·Clinical and Experimental Immunology·J DongJ Li
May 8, 2014·British Journal of Clinical Pharmacology·Wei-Jian PanDominic C Borie
May 13, 2014·Lancet·Séverine VermeirePaul Rutgeerts